- GlobeNewswire•8 days ago
DURHAM, N.C., Oct. 17, 2016-- Heat Biologics, Inc., an immuno-oncology company developing novel therapies that activate a patient’ s immune system against cancer, announced that Jeff Wolf, CEO of Heat ...
- GlobeNewswire•12 days ago
DURHAM, N.C., Oct. 13, 2016-- Heat Biologics, Inc., an immuno-oncology company developing novel therapies that activate a patient’ s immune system against cancer, announced that it continues to remain ...
- GlobeNewswire•14 days agoHeat Biologics Selects Adaptive Biotechnologies to Discover Potential Clinical Biomarkers to Advance Novel Immunotherapies
DURHAM, N.C., Oct. 11, 2016-- Heat Biologics, Inc., announced that they have advanced their biomarker discovery collaboration with Adaptive Biotechnologies. Adaptive will use its patented immune profiling ...
Heat Biologics, Inc. (HTBX)
NasdaqCM - NasdaqCM Real Time Price. Currency in USD
|Bid||1.29 x 5500|
|Ask||1.35 x 800|
|Day's Range||1.21 - 1.32|
|52wk Range||0.40 - 4.98|
|1y Target Est||N/A|
Trade prices are not sourced from all markets
|P/E Ratio (ttm)||-0.74|
|Avg Vol (3m)||1,679,881|
|Dividend & Yield||N/A (N/A)|